These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 7523748)
1. [Basic and clinical studies on serum cytokeratin 19 fragment assay using Centocor CYFRA 21-1 kit in patients with lung cancer]. Hamase A; Sugimoto Y; Maeda M; Kitani H; Fukuchi M Kaku Igaku; 1994 Aug; 31(8):969-76. PubMed ID: 7523748 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of a cytokeratin 19 assay kit "BALL ELSA CYFRA21-1"]. Sakahara H; Kousaka T; Hattori N; Hosono M; Kobayashi H; Shirato M; Yao Z; Konishi J Kaku Igaku; 1993 Dec; 30(12):1475-9. PubMed ID: 7509008 [TBL] [Abstract][Full Text] [Related]
3. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Pujol JL; Grenier J; Daurès JP; Daver A; Pujol H; Michel FB Cancer Res; 1993 Jan; 53(1):61-6. PubMed ID: 7677981 [TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of CYFRA assay in diagnosing lung cancer: measurement of serum cytokeratin fragment. Sugama Y; Kitamura S; Kawai T; Ohkubo A; Hasegawa S; Kuriyama T; Kato H; Fukuoka M; Ohkawa J Jpn J Cancer Res; 1994 Nov; 85(11):1178-84. PubMed ID: 7530241 [TBL] [Abstract][Full Text] [Related]
5. [The evaluation of the newly produced assay kit for the cytokeratin fragment, "ball ELSA CYFRA21-1"]. Kimura Y; Ata M; Nakamura S; Fujii T; Kawamura T; Tanada S; Hamamoto K Kaku Igaku; 1994 Feb; 31(2):199-206. PubMed ID: 7509886 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma. Huang MS; Jong SB; Tsai MS; Lin MS; Chong IW; Lin HC; Hwang JJ Respir Med; 1997 Mar; 91(3):135-42. PubMed ID: 9135852 [TBL] [Abstract][Full Text] [Related]
7. Cytokeratin fragment 19 (CYFRA 21-1) as a tumor marker in non-small cell lung cancer. Huang MS; Jong SB; Lin MS; Chong IW; Tsai MS; Lin HC; Hwang JJ Kaohsiung J Med Sci; 1996 Feb; 12(2):62-8. PubMed ID: 8709175 [TBL] [Abstract][Full Text] [Related]
8. Assessment of serum CYFRA 21-1 in lung cancer. Muraki M; Tohda Y; Iwanaga T; Uejima H; Nagasaka Y; Nakajima S Cancer; 1996 Apr; 77(7):1274-7. PubMed ID: 8608502 [TBL] [Abstract][Full Text] [Related]
9. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role. Wieskopf B; Demangeat C; Purohit A; Stenger R; Gries P; Kreisman H; Quoix E Chest; 1995 Jul; 108(1):163-9. PubMed ID: 7541742 [TBL] [Abstract][Full Text] [Related]
10. Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation. Giovanella L; Ceriani L; Bandera M; Rimoldi R; Beghé B; Roncari G Q J Nucl Med; 1995 Dec; 39(4):285-9. PubMed ID: 8624791 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of BEKI TPS radioassay kit as a one-step immunoradiometric assay utilizes monoclonal and polyclonal antibodies specific for serum tissue polypeptide antigen]. Hamase A; Kawanaka M; Kitani H; Fukuchi M Kaku Igaku; 1994 Aug; 31(8):995-1003. PubMed ID: 7933689 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: results of a multicenter trial. Bombardieri E; Seregni E; Bogni A; Ardit S; Belloli S; Busetto A; Caniello B; Castelli M; Cianetti A; Correale M Int J Biol Markers; 1994; 9(2):89-95. PubMed ID: 7523547 [TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study. Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259 [TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer. Maeda Y; Segawa Y; Takigawa N; Takata I; Fujimoto N Intern Med; 1996 Oct; 35(10):764-71. PubMed ID: 8933183 [TBL] [Abstract][Full Text] [Related]
15. Comparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases. Stieber P; Dienemann H; Hasholzner U; Fabricius PG; Schambeck C; Weinzierl M; Poley S; Samtleben W; Hofmann K; Meier W Int J Biol Markers; 1994; 9(2):82-8. PubMed ID: 7523546 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1. van der Gaast A; Schoenmakers CH; Kok TC; Blijenberg BG; Cornillie F; Splinter TA Br J Cancer; 1994 Mar; 69(3):525-8. PubMed ID: 7510117 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer. Gaarenstroom KN; Bonfrer JM; Kenter GG; Korse CM; Hart AA; Trimbos JB; Helmerhorst TJ Cancer; 1995 Sep; 76(5):807-13. PubMed ID: 8625184 [TBL] [Abstract][Full Text] [Related]
18. CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21-1 Multicentre Study Group. Rastel D; Ramaioli A; Cornillie F; Thirion B Eur J Cancer; 1994; 30A(5):601-6. PubMed ID: 7521651 [TBL] [Abstract][Full Text] [Related]
19. Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer. Trevisani L; Putinati S; Sartori S; Abbasciano V; Bagni B Chest; 1996 Jan; 109(1):104-8. PubMed ID: 8549168 [TBL] [Abstract][Full Text] [Related]
20. CYFRA 21-1 as a tumor marker used in measuring the serum fragment of cytokeratin subunit 19 by immunoradiometric assay. Sarwar M; Tomiyoshi K; Inoue T; Fukazawa K; Endo K Ann Nucl Med; 1994 Nov; 8(4):301-6. PubMed ID: 7535552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]